Truist Securities analyst Robyn Karnauskas initiates coverage on Curis (NASDAQ:CRIS) with a Buy rating and announces Price Target of $26.
Truist Securities Initiates Coverage On Curis With Buy Rating, Announces Price Target of $26
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.